Electromed, Inc. (ELMD)

NYSE American • Currently up 0.40 (+1.49%) in today's trading session

1 member of Congress has disclosed 18 trades in Electromed, Inc. (ELMD) via STOCK Act filings. The most recent disclosure was a sale by Paul Mitchell on 9 June 2020. Aggregate disclosed activity totals roughly $960K in purchases and $1.7M in sales (midpoint estimates from bracketed disclosure amounts).

Electromed, Inc. is currently trading at $27.17, positioned at 17% of its 52-week range ($23.01 – $47.40).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$27.17
24h Change
+0.40 (+1.49%)
52 Week Range
$23.01–$47.40
View on NASDAQ

Electromed, Inc. Price History and Technical Analysis

Congressional Trading Activity for ELMD

Select to highlight on chart
5 transactions
Compliance: 0%
Paul Mitchell9 Jun 202019 Jan 2021SaleStock$15,001 - $50,000N/A
Paul Mitchell9 Jun 202019 Jan 2021SaleStock$15,001 - $50,000N/A
Paul Mitchell20 May 202019 Jan 2021PurchaseStock$15,001 - $50,000N/A
Paul Mitchell20 May 202019 Jan 2021PurchaseStock$15,001 - $50,000N/A
Paul Mitchell8 May 202019 Jan 2021SaleStock$500,001 - $1,000,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$225.16M

Volume

40.94K

Beta

0.43

P/E Ratio

20.74

Fundamentals

EPS

$1.31

Div. Yield

-

Open

$27.26

Day Range

$26.66 – $27.49

Company Information

Sector
Healthcare
Industry
Medical - Devices
Exchange
AMEX · USD
Country
US
CEO
James L. Cunniff
IPO Date
2010-08-13

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The co...

Earnings

Next Report

Q3 2026

10 Nov

EPS Est.

$0.26

Rev. Est.

$18.9M

Days Until

1

Recent Quarters

Q2 202625 Aug
EPS$0.39
Beat 23.1%
Q1 202612 May
EPS$0.35
Beat 34.6%
Q4 202510 Feb
EPS$0.32
Beat 18.5%
Q3 202512 Nov
EPS$0.25
Beat 13.6%
Q2 202526 Aug
EPS$0.25
Beat 13.6%
Q1 202513 May
EPS$0.21
Beat 5.0%
Q4 202411 Feb
EPS$0.22
Beat 22.2%
Q3 202412 Nov
EPS$0.16
Beat 433.3%
Q2 202427 Aug
EPS$0.20
Beat 42.9%
Q1 20247 May
EPS$0.17
Beat 30.8%
Q4 202313 Feb
EPS$0.19
Beat 90.0%
Q3 20237 Nov
EPS$0.02
Miss 80.0%
Q2 202322 Aug
EPS$0.12
Miss 7.7%
Q1 20239 May
EPS$0.12
Beat 20.0%
Q4 202214 Feb
EPS$0.11
Beat 214.3%
Q3 20228 Nov
EPS$0.01
Miss 71.4%
Q2 202223 Aug
EPS$0.04
Miss 50.0%
Q1 202210 May
EPS$0.07
Beat 40.0%
Q4 20218 Feb
EPS$0.10
Beat 42.9%
Q3 20219 Nov
EPS$0.05
Miss 16.7%
Q2 202124 Aug
EPS$0.04
Miss 33.3%
Q1 202111 May
EPS$0.03
Miss 50.0%
Q4 20209 Feb
EPS$0.13
Beat 225.0%
Q3 202010 Nov
EPS$0.06
Beat 220.0%
Q2 202025 Aug
EPS$0.15
Beat 200.0%
Q1 202012 May
EPS$0.07
Beat 16.7%
Q4 201911 Feb
EPS$0.14
Beat 218.2%
Q3 201912 Nov
EPS$0.12
Beat 1100.0%
Q2 201927 Aug
EPS$0.13
Q1 20197 May
EPS$0.04
Q4 201812 Feb
EPS$0.04
Q3 201813 Nov
EPS$0.02
Q2 201825 Sept
EPS$0.13
Q1 20188 May
EPS$0.04
Q4 201713 Feb
EPS$0.06
Q3 20177 Nov
EPS$0.01
Q2 20175 Sept
EPS$0.11
Q1 201715 May
EPS$0.08
Q4 20167 Feb
EPS$0.05
Beat 66.7%
Q3 20168 Nov
EPS$0.02
Miss 33.3%
Q2 20166 Sept
EPS$0.04
Miss 20.0%
Q1 201610 May
EPS$0.06
Miss 14.3%
Q4 20159 Feb
EPS$0.13
Beat 160.0%
Q3 201510 Nov
EPS$0.04
Q2 201515 Sept
EPS$0.03
Beat 50.0%
Q1 201512 May
EPS$0.00
Miss 77.2%
Q4 201410 Feb
EPS$0.05
Q3 201412 Nov
EPS$0.05
Beat 600.3%
Q2 201423 Sept
EPS$0.04
Q1 201413 May
EPS$-0.12
Q4 201311 Feb
EPS$-0.03
Beat 0.0%
Q3 201312 Nov
EPS$-0.04
Miss 100.0%
Q2 201325 Sept
EPS$-0.05
Beat 0.0%
Q1 201314 May
EPS$-0.05
Miss 66.7%
Q4 201213 Feb
EPS$-0.05
Miss 600.0%
Q3 201213 Nov
EPS$-0.01
Miss 49.9%
Q2 201224 Sept
EPS$-0.02
Miss 300.0%
Q1 201214 May
EPS$0.01
Miss 66.7%
Q4 201113 Feb
EPS$0.00
Q3 20118 Nov
EPS$0.03
Beat 0.0%
Q2 201112 Sept
EPS$0.02
Miss 33.3%
Q1 201112 May
EPS$0.06
Beat 71.4%
Q4 201010 Feb
EPS$0.04
Miss 20.0%
Q3 201015 Nov
EPS$0.02
Beat 0.0%
Q3 201012 Nov
EPS$0.02
Q4 200931 Mar
EPS$0.08
Q3 200931 Dec
EPS$0.01
Q2 200930 Sept
EPS$0.05
Q1 200930 Jun
EPS$0.03

2 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

UFPT

UFP Technologies, Inc.

72
$303.47+3.65 (+1.22%)
Healthcare
Held by same politician
Same sector: Healthcare
+1 more reason
1 politician
View Stock

MYRG

MYR Group Inc.

42
$262.91+16.32 (+6.62%)
Industrials
Held by same politician
$21M in total holdings
1 politician
View Stock

LMB

Limbach Holdings, Inc.

40
$53.45-1.05 (-1.93%)
Basic Materials
Held by same politician
Significant holdings value
1 politician
View Stock

Frequently Asked Questions about ELMD

Which members of Congress have traded ELMD?
1 member of Congress has disclosed 18 trade in Electromed, Inc. (ELMD) under the STOCK Act: Paul Mitchell.
When was ELMD most recently disclosed by Congress?
The most recent ELMD disclosure was a sale by Paul Mitchell on 9 June 2020.
What is the total disclosed congressional trading volume for ELMD?
Members of Congress have disclosed approximately $960K in ELMD purchases and $1.7M in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in ELMD?
This ELMD page updates as soon as new STOCK Act disclosures are filed for Electromed, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.